R. Dale Brown, Kendall S. Hunter, Min Li, Maria G. Frid, Julie Harral, Greta M. Krafsur, Timothy N. Holt, Jason Williams, Hui Zhang, Suzette R. Riddle, Michael G. Edwards, Sushil Kumar, Cheng-Jun Hu, Brian B. Graham, Lori A. Walker, Franklyn B. Garry, Peter M. Buttrick, Tim Lahm, Vitaly O. Kheyfets, Kirk C. Hansen, Kurt R. […]
Raquel F. Videira, Anne-Marie C. Koop, Lara Ottaviani, Ella M. Poels, Jordy M. M. Kocken, Cristobal Dos Remedios, Pedro Mendes-Ferreira, Kees W. Van De Kolk, Gideon J. Du Marchie Sarvaas, Andre´ Lourenc, Aida Llucia`-Valldeperas, Diana S. Nascimento, Leon J. De Windt, Frances S. DeMan, Ineˆs Falc~ao-Pires, Rolf M. F. Berger, Paula A. da Costa MartinsMaastricht
Yang Liu, Yanna Li, Jun Zhang, Dawei Zhang, Jiachen Li, Yichen Zhao, Kemin Liu, Xiaolong Ma, Chen Bai, Hong Gu, Xiangming Fan, Jiangang WangBeijing Anzhen Hospital Affiliated to Capital Medical University. China Pulmonary CirculationPulm Circ 2022; 12: DOI: 10.1002/pul2.12079 AbstractAs pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) may increase maternal and fetal risk, this
Katharina Schimmel, Kenzo Ichimura, Sushma Reddy, Francois Haddad, Edda SpiekerkoetterStanford University School of Medicine. United States Frontiers in Cardiovascular MedicineFront Cardiovasc Med 2022; 9: DOI: 10.3389/fcvm.2022.886553 AbstractMyocardial fibrosis is a remodeling process of the extracellular matrix (ECM) following cardiac stress. “Replacement fibrosis” is a term used to describe wound healing in the acute phase of an
Maria Anifanti, Stavros Giannakoulakos, Elpis Hatziagorou, Asterios Kampouras, John Tsanakas, Asterios Deligiannis, Evangelia KouidiAristotle University of Thessaloniki and Hippokration Hospital. Greece SensorsSensors 2022; 22: DOI: 10.3390/s22134884 AbstractSeveral studies have shown that patients with cystic fibrosis (CF), even at a young age, have pulmonary and cardiac abnormalities. The main complications are cardiac right ventricular (RV) systolic and/or
Dongli Liu, Suyuan Qin, Danyan Su, Kai Wang, Yanyun Huang, Yuqin Huang, Yusheng PangThe First Affiliated Hospital of Guangxi Medical University. The First Affiliated Hospital of Wenzhou Medical University.China American Chemical Society OmegaACS Omega 2021; 7: 1273-1287DOI: 10.1021/acsomega.1c05895 AbstractPulmonary arterial hypertension (PAH) is a complex devastating disease relevant to remarkable metabolic dysregulation. Although various research studies
Gregory P. Barton, Philip A. Corrado, Christopher J. Francois, James R. Runo, Naomi C. Chesler, Alan B. McMillan, Oliver Wieben, Kara N. GossUniversity of Wisconsin. University of Texas Southwestern Medical Center. University of California-Irvine. United States Pulmonary CirculationPulm Circ 2022; DOI: 10.1002/pul2.12025 AbstractNo Abstract Available CategoryClass I. Pulmonary Hypertension Associated with Connective Tissue DiseasePulmonary Hypertension Associated
Emmanuelle Fournier, Maëlle Selegny, Myriam Amsallem, Francois Haddad, Sarah Cohen, Estibaliz Valdeolmillos, Jérôme Le Pavec, Marc Humbert, Marc-Antoine Isorni, Arshid Azarine, Olivier Sitbon, Xavier Jais, Laurent Savale, David Montani, Elie Fadel, Joy Zoghbi, Emre Belli, Sebastien HascoëtMarie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph and Paris-Saclay University. Stanford University School of Medicine. Marie Lannelongue Hospital.
Kwaku D. Tawiah, Caroline E. Franks, Jessica Tang, Avihu Gazit, Dennis J. Dietzen, Christopher W. FarnsworthWashington University School of Medicine. National Institutes of Health.United States Clinical BiochemistryClin Biochem 2022; 109-110: 74-78DOI: 10.1016/j.clinbiochem.2022.08.003 AbstractBackground: B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are essential biomarkers for the evaluation of cardiac pathologies. However, pediatric reference intervals for
Comparison between BNP and NT-proBNP in pediatric populations Read More »
Daniel Chilcote, Laura Mercer-Rosa, Yan Wang, Steven M. Kawut, Robert A. Berg, Nadir Yehya, Adam S. HimebauchPerelman School of Medicine at the University of Pennsylvania and Children’s Hospital of Philadelphia. United States Pediatric PulmonologyPediatr Pulmonol 2023; 58: 559-565DOI: 10.1002/ppul.26237 AbstractPrimary hypothesis: We hypothesized that higher alveolar dead space fraction (AVDSf) at pediatric acute respiratory distress syndrome (PARDS)
